Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UG, United Kingdom
Daktarin 2% Cream.
| Pharmaceutical Form |
|---|
|
Cream. White homogeneous cream. |
Miconazole nitrate 2% w/w.
Excipients: Benzoic acid, Butylated hydroxyanisole.
For a full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Miconazole |
Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis. |
| List of Excipients |
|---|
|
PEG-6, PEG-32 and glycol stearate |
Aluminium tube inner lined with heat polymerised epoxy-phenol resin with a white polypropylene cap containing 15g, 30g or 70g of cream, or aluminium tube inner lined with heat polymerised epoxy-phenol resin with a high density polyethylene cap containing 5g of cream.
Not all pack sizes may be marketed.
McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UG, United Kingdom
PL 15513/0307
01/04/2009
| Drug | Countries | |
|---|---|---|
| DAKTARIN | Austria, Australia, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
